MarketWatch

Mercy Halo Blood Test Shows Promise in Early Lung Cancer Detection: New Study Shows Performance Similar to LDCT with Clinical Complementarity

The MarketWatch News Department was not involved in the creation of this content. WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of ...
Morningstar

Mercy BioAnalytics Publishes Validation Study in Gynecologic Oncology Demonstrating Unprecedented Performance of Blood Test for Early Detection of Ovarian Cancer

Test demonstrates 89% sensitivity for detection of preclinical stage I/II high grade serous ovarian cancer at 98% specificity in average risk postmenopausal women WALTHAM, Mass., Oct. 28, 2025 ...
KTLA

Mercy Halo Blood Test Shows Promise in Early Lung Cancer Detection: New Study Shows Performance Similar to LDCT with Clinical Complementarity

WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples ...